The London-based European Medicine Agency (EMA) will need a new home after Brexit, and almost a dozen European cities are already vying over the regulatory gem.
Today, almost all new or innovative medicines are submitted to EMA for assessment, which evaluates whether they are safe to put on the EU market. The agency comes with almost 900 expert workers, paid for by the EU; comprehensive research networks; and a €300 million a year budget.
Acting as a host for EMA is a boon for a...
Enjoy access to all articles and 25 years of archives, comment and gift articles. Become a member for as low as €1,75 per week.
Already a member? Login